Press Release PureTech Founded Entity Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) 13 July 2026
Press Release Celea Therapeutics Doses First Patient in Global Phase 3 SURPASS-IPF Trial Evaluating Deupirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) 13 July 2026
Press Release MileOne Autogroup Ranked Highest in New 2026 Service Scheduling Effectiveness Omnichannel Study 13 July 2026
Press Release Churchill Asset Management and Seviora Close Approximately $400 Million Collateralized Fund Obligation Combining U.S. and Asian Private Capital Strategies 13 July 2026
Press Release Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Provides New Details on Upgrading Its Robotics Strategy to the “Four-Core Full-Stack AI” and Q3 Robotics Practical Deployment Campaign 12 July 2026
Press Release Takeda and the Indonesian Government Announce Landmark Collaboration to Strengthen Healthcare Resilience and Expand Access to Lifesaving Plasma-Derived Medicinal Products 12 July 2026
Press Release Concord Technologies Releases New Report on AI-Driven Interoperability and Operational Efficiency 12 July 2026
Press Release CaringAI Presents Research at AAIC 2026 Showing Strong Clinician Agreement with AI-Powered Telephone Cognitive Screening 12 July 2026
